Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	139.95	81.94	34.15
Graham Fair Price	-35.93	15.52	24.23
PEG	414.18	-0.54	0.11
Price/Book	6.88	3.50	3.27
Price/Cash Flow	inf	0.00	57.07
Prices/Earnings	166.70	32.13	12.05
Price/Sales	100.50	35.81	17.86
Price/FCF	inf	0.00	57.07
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	19.13	0.75	0.63
Operating Margin	-7.01	0.43	0.46
ROA	-58.95	0.02	0.05
ROE	0.07	0.03	-59.92
ROIC	0.05	0.03	-49.95
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.24	-0.20	-16.43
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.78	-0.50	-35.37
EPS QOQ	1.15	-0.59	-48.13
FCF QOQ	0.00	-1.00	-100.00
Revenue QOQ	0.92	-0.47	-49.29
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	17.14	25.40	48.20
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.13	0.09	-29.45
Quick Ratio	0.47	0.38	-18.68
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	19.60	19.83	1.20
Cash	0.66	0.47	-28.36
Capex	-0.16	0.00	inf
Free Cash Flow	1.12	0.00	inf
Revenue	3.59	1.94	-46.05
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.49	0.50	2.47
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.98	1.73	77.22
Naive Interpretation	Member

06 - Financial Health · Bad

Rating